Tecres partners with Keensight to create Demetra Holding
Tecres, a medical technology company dedicated to the development of bone cements and bone substitutes and private equity firm Keensight Capital have invested in Demetra Holding. This new Group, led by Tecres’ shareholders, combines two of the major players in the field of bone cement and biomaterials, Tecres SpA (Italy-based)